Pfizer, Moderna Face New IP Litigation Over COVID Vaccines
Pfizer and Moderna on Tuesday were targeted in another round of patent suits by rival Alnylam Pharmaceuticals over their COVID-19 vaccines, months after Alnylam claimed the vaccines ripped off a different...To view the full article, register now.
Already a subscriber? Click here to view full article